Antibiotics and similar drugs, together called antimicrobial agents, have been used for the last 70 years to treat patients who have infectious diseases.Contact Us
Since the 1940s, these drugs have greatly reduced illness and death from infectious diseases. However, these drugs have been used so widely and for so long that the infectious organisms the antibiotics are designed to kill have adapted to them, making the drugs less effective. Antibiotic-resistant bacteria are responsible for infecting at least 2 million people annually in the United States and at least 23,000 people die due to these infections.1
Antibiotic Resistance comes from a confluence of factors:
As the CDC states, a growing body of evidence demonstrates that hospital-based programs dedicated to improving antibiotic use, commonly referred to as “Antibiotic Stewardship Programs (ASPs)”, can both optimize the treatment of infections and reduce adverse events associated with antibiotic use.2,3
McKesson is proud to offer a comprehensive solution for Antibiotic Stewardship. Our goal is to improve patient safety and conserve antibiotics in all communities nationwide by offering solutions that augment the good work hospitals have already implemented. Our experienced team will work closely with stewardship teams to move from current state to a jointly defined ideal state.
In 2015, the White House hosted the Forum on Antibiotic Stewardship to bring together more than 100 key human and animal health leaders involved in antibiotic stewardship-the development, promotion, and implementation of activities to promote optimal use of antibiotics nationwide. They put forth a national action plan that included:
- 50% reduction of C. difficile incidents
- 60% reduction in hospital-acquired CRE infections
- 35% reduction in hospital-acquired MDR Pseudomonas species infections
- 50% reduction in MRSA bloodstream infections
- 50% reduction in inappropriate antibiotic use in outpatient settings and a 20% reduction in inpatient settings
Is your facility on pace to meet the call to action? Are you leveraging Aggressive Diagnostics, Coordinated Data and Clinical Collaboration to aide these efforts?
Through customer interviews at hospitals like yours, McKesson has identified three critical components of successful Antibiotic Stewardship Programs. Watch our webinar and panel presentation on how these critical components help reduced hospital acquired infections, patient length of stay and improve overall patient satisfaction here. (Registration required.)
Learn more about each critical component of Antibiotic Stewardship Programs that support improved patient outcomes:
Want More Information?
Contact McKesson’s Specialists to learn how McKesson’s Solution for Antibiotic Stewardship can help you work towards these goals and make a positive impact in patient therapy.
What Characteristics Define a Successful Antibiotic Stewardship Program?
Take our latest assessment to reveal whether your facility meets the characteristics of a high-performing antibiotic stewardship program.
1 – https://www.cdc.gov/drugresistance/index.html
2 – https://www.cdc.gov/antibiotic-use/healthcare/implementation/core-elements.html#_ENREF_17
3 – https://www.cdc.gov/antibiotic-use/healthcare/implementation/core-elements.html#_ENREF_18
Statistics in graphic:
$35B to $45B – https://www.cdc.gov/hai/pdfs/hai/scott_costpaper.pdf
12M – https://qualitysafety.bmj.com/content/early/2014/04/04/bmjqs-2013-002627
1 in 25 – https://www.cdc.gov/hai/surveillance/index.html
Only 49% – https://www.pharmacytoday.org/article/S1042-0991(17)31637-7/pdf
50% – https://www.cdc.gov/antibiotic-use/stewardship-report/pdf/stewardship-report.pdf
18% – https://www.hcup-us.ahrq.gov/reports/statbriefs/sb196-Readmissions-Trends-High-Volume-Conditions.pdf